Cognition Therapeutics
CGTX
CGTX
69 hedge funds and large institutions have $28.7M invested in Cognition Therapeutics in 2025 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 23 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
10.83% more ownership
Funds ownership: 18.1% → 28.93% (+11%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
69
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$3.63M | |
| 2 | +$1.86M | |
| 3 | +$1.62M | |
| 4 |
Jane Street
New York
|
+$1.23M |
| 5 |
BlackRock
New York
|
+$1.2M |
Top Sellers
| 1 | -$216K | |
| 2 | -$203K | |
| 3 | -$77.5K | |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$48.3K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$28.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Goldman Sachs
New York
| – |
|
|||
|
AC
77
Apella Capital
West Hartford,
Connecticut
| – |
|